ACL

Alchemia (ACL)

Thu, 17/07/2008 - 09:30

Stock Code

ACL

Stock Exchange

Australian Securities Exchange

Alchemia (ACL) is a biotechnology company. The Company’s principal activities incorporate the development of carbohydrate-based molecules for therapeutic applications, based on its drug discovery and synthesis technologies. Alchemia was listed on the Australian Stock Exchange ASX on 23rd of December, 2003. Alchemia along with its subsidiaries is engaged in the research and development of new human pharmaceuticals.

Alchemia (ACL) Stock Recommendation

Sat, 05/08/2006 - 15:01

ABN Amro has rated the Alchemia (ACL) stock with a Buy and a valuation of $3.55 per share. The broker has noted that the company has also entered a collaboration with another European drug company to search for new drug candidates, providing future upside potential if any successful developments are made.

Top ASX Stock Picks for 2006: Small Caps

Tue, 17/01/2006 - 21:03

These are the Top ASX Stock Picks for 2006 for the Small Caps provided by ABN Amro:

CDO, TBG, ARQ, CBH, QCG, ABC, ACL, CCP, QMT, OAK.

Now, I'm not suggesting you go out and buy these top picks for the small caps stocks arena - they may look cheap, may have a lot of upside but you also have to consider what you exit plan is if you do decide to trade these small cap stocks.

Syndicate content

Free Email Subscription to Share Trading

 My Share Trading Feed